Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jun;56(6):1413-1421.
doi: 10.1161/STROKEAHA.124.048215. Epub 2025 Mar 27.

Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection

Daniel M Mandel  1 Liqi Shu  1 Christopher Chang  1 Naomi Jack  1 Christopher R Leon Guerrero  2 Nils Henninger  3 Jayachandra Muppa  3 Muhammad Affan  4 Omair Ul Haq Lodhi  4 Mirjam R Heldner  5 Kateryna Antonenko  5 David Seiffge  5 Marcel Arnold  5 Setareh Salehi Omran  6 Ross Crandall  6 Evan Lester  6 Diego Lopez Mena  7 Antonio Arauz  7 Ahmad Nehme  8 Marion Boulanger  8 Emmanuel Touzé  8 Joao Andre Sousa  9 Joao Sargento-Freitas  9 Vasco Barata  9 Paulo Castro-Chaves  10 Maria Teresa Brito  10 Muhib Khan  11   12 Dania Mallick  11 Aaron Rothstein  13 Ossama Khazaal  13 Josefin E Kaufman  14 Stefan T Engelter  14 Christopher Traenka  14 Diana Aguiar de Sousa  15 Mafalda Soares  16 Sara Rosa  17 Lily W Zhou  18 Preet Gandhi  18 Thalia S Field  18 Steven Mancini  18 Issa Metanis  19 Ronen R Leker  19 Kelly Pan  1 Vishnu Dantu  1 Karl Baumgartner  1 Tina Burton  1 Regina von Rennenberg  20 Christian H Nolte  20 Richard Choi  21 Jason MacDonald  21 Reza Bavarsad Shahripour  22 Xiaofan Guo  23 Malik Ghannam  24 Mohammad Almajali  24 Edgar A Samaniego  24 Sebastian Sanchez  24 Bastien Rioux  25 Faycal Zine-Eddine  25 Alexandre Poppe  25 Ana Catarina Fonseca  26 Maria Fortuna Baptista  26 Diana Cruz  26 Michele Romoli  27 Giovanna De Marco  27 Marco Longoni  27 Zafer Keser  12 Kim Griffin  12 Lindsey Kuohn  28 Jennifer Frontera  28 Jordan Amar  29 James Giles  29 Marialuisa Zedde  30 Rosario Pascarella  31 Ilaria Grisendi  30 Hipolito Nzwalo  32 David S Liebeskind  33 Amir Molaie  33 Annie Cavalier  34 Wayneho Kam  35 Brian Mac Grory  34 Sami Al Kasab  36 Mohammad Anadani  36 Kimberly Kicielinski  37 Ali Eltatawy  38 Lina Chervak  38 Roberto Chulluncuy Rivas  38 Yasmin Aziz  38 Ekaterina Bakradze  39 Thanh Lam Tran  39 Marc Rodrigo Gisbert  40 Manuel Requena  40 Faddi Saleh Velez  41 Jorge Ortiz Garcia  41 Varsha Muddasani  42 Adam de Havenon  43   44 Venugopalan Y Vishnu  45 Sridhara Yaddanapudi  46 Latasha Adams  46 Abigail Browngoehl  46 Tamra Ranasinghe  47 Randy Dunston  47 Zachary Lynch  47 Mary Penckofer  48 James E Siegler  48 Silvia Mayer  49 Joshua Willey  49 Adeel Zubair  43 Yee Kuang Cheng  43 Richa Sharma  43 João Pedro Marto  50 Vítor Mendes Ferreira  50 Piers Klein  51 Thanh N Nguyen  51 Syed Daniyal Asad  52 Zoha Sarwat  52 Anvesh Balabhadra  52 Shivam Patel  52 Thais Secchi  53 Sheila Martins  53   54 Gabriel Mantovani  54 Young Dae Kim  55 Balaji Krishnaiah  56 Cheran Elangovan  56 Sivani Lingam  57 Abid Y Qureshi  57 Sebastian Fridman  58 Alonso Alvarado-Bolanos  58 Farid Khasiyev  59 Guillermo Linares  59 Marina Mannino  60 Valeria Terruso  60 Sofia Vassilopoulou  61 Vasileios Tentolouris-Piperas  61 Manuel Martinez Marino  62 Victor Carrasco Wall  62 Fransisca Indraswari  63 Sleiman El Jamal  63 Shilin Liu  64 Muhammad Alvi  65 Farman Ali  65 Mohammed Sarvath  65 Rami Z Morsi  66 Tareq Kass-Hout  66 Feina Shi  67 Jinhua Zhang  67 Dilraj Sokhi  68 Jamil Said  68 Newnex Mongare  68 Alexis N Simpkins  69 Roberto Gomez  69 Shayak Sen  69 Mohammad Ghani  70 Marwa Elnazeir  70 Han Xiao  71 Narendra Kala  1 Farhan Khan  1 Christoph Stretz  1 Nahid Mohammadzadeh  1 Eric Goldstein  1 Karen Furie  1 Shadi Yaghi  1
Affiliations
Observational Study

Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection

Daniel M Mandel et al. Stroke. 2025 Jun.

Abstract

Background: Patients presenting with cervical artery dissection (CAD) are at risk for subsequent ischemic events. We aimed to identify characteristics that are associated with increased risk of ischemic stroke after initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals.

Methods: This was a preplanned secondary analysis of the STOP-CAD study (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection), a multicenter international retrospective observational study (63 sites from 16 countries in North America, South America, Europe, Asia, and Africa) that included patients with CAD predominantly between January 2015 and June 2022. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Clinical and imaging variables were compared between those with versus without subsequent ischemic stroke. Significant factors associated with subsequent stroke risk were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type (anticoagulation versus antiplatelets) among patients with identified risk factors were explored using adjusted Cox regression.

Results: In all, 4023 patients (mean age was 47.4 years; 44.5% were women) were included. By day 180, subsequent ischemic stroke occurred in 5.3% of the cohort. In adjusted Cox regression, factors associated with increased risk of subsequent ischemic stroke were prior history of ischemic stroke (adjusted hazard ratio [aHR], 7.31 [95% CI, 1.61-33.13]; P=0.010), presentation within 7 days from first symptoms (aHR, 3.04 [95% CI, 1.04-8.91]; P=0.043), infarct on baseline imaging (aHR, 9.85 [95% CI, 3.65-26.58]; P<0.001), and occlusive dissection (aHR, 2.34 [95% CI, 1.03-5.34]; P=0.043). Only patients with occlusive dissection demonstrated a reduced risk of subsequent ischemic stroke when treated with anticoagulation versus antiplatelets (aHR, 0.36 [95% CI, 0.16-0.80]; P=0.01).

Conclusions: In this post hoc analysis of the STOP-CAD study, several factors associated with subsequent ischemic stroke were identified among patients with CAD. Furthermore, we identified a potential benefit of anticoagulation in patients with CAD with occlusive dissection. These findings require validation by meta-analyses of prior studies to formulate optimal treatment strategies for specific high-risk CAD subgroups.

Keywords: arteries; fibrinolytic agents; infarction; ischemic stroke; platelet aggregation inhibitors.

PubMed Disclaimer

Conflict of interest statement

Dr Heldner reports grants from Swiss National Science Foundation, Swiss Heart Foundation, and SITEM Research Funds. Dr Antonenko reports grants from Swiss National Science Foundation. Dr Seiffge reports grants from AstraZeneca and compensation from AstraZeneca for consultant services. Dr Arnold reports compensation from Novo Nordisk; Covidien, Medtronic; Amgen; AstraZeneca, Bayer, Bristol Myers Squibb, Covidien, Daiichi Sankyo, Novartis, Sanofi, Pfizer; and Boehringer Ingelheim for consultant services. Dr Touzé reports employment by Caen and compensation from Elsevier for other services. Dr M. Khan reports compensation from Fred Hutchinson Cancer Research Center for end point review committee services and grants from Mayo Foundation for Medical Education and Research. Dr Rothstein reports grants from American Heart Association. Dr Rosa reports grants from Merck Sharp and Dohme Corporation. Dr Field reports compensation from Bayer for consultant services, HLS Therapeutics, AstraZeneca Canada, and Novartis for consultant services; service as Board Member for Destine Health; and compensation from Canadian Medical Protective Association for expert witness services. Dr Poppe reports compensation from Roche for other services; grants from Heart and Stroke Foundation of Canada, Foundation Brain Canada, Canadian Institutes of Health Research, and Stryker. Dr Aguiar de Sousa reports compensation from AstraZeneca, Bayer, Daiichi Sankyo, Fundação Bial, Johnson and Johnson, for other services, compensation from Organon & Co. for consultant services, compensation from University of British Columbia for Data and Safety Monitoring services. Dr Liebeskind reports compensation from Cerenovus, Genentech, Medtronic, Stryker, and Rapid Medical Ltd for consultant services. Dr Mac Grory reports grants from Duke Bass Connections, National Institutes of Health, American Heart Association, and Duke Office of Physician Scientist Development; and employment by Duke University Medical Center. Dr Kicielinski reports employment by Medical University of South Carolina and Elsevier; and compensation from Penumbra Inc for other services. Dr Siegler reports compensation from AstraZeneca for other services; employment by Cooper Hospital and University of Chicago; grants from Viz.ai; grants from Philips. Dr Sharma reports grants from the National Institutes of Health Clinical Center and a provisional patent has filed a provisional patent for a stroke etiology classifier algorithm. Dr Martins reports compensation from Boehringer Ingelheim, Penumbra Inc, Novartis, Novo Nordisk, Medtronic, Bayer, Daiichi Sankyo Company; AstraZeneca, Servier Affaires Medicales, and Pfizer for other services. Dr Sokhi reports compensation from F. Hoffmann-La Roche for other services. Dr Simpkins reports compensation from National Institute of Neurological Disorders and Stroke for data and safety monitoring services; compensation from Up to Date for other services; and grants from National Institutes of Health. Dr Stretz has received funding from Massachusetts General Hospital/BSC and Duke University Medical Center/National Institutes of Health (302000478/5K23HL161426- 02), and receives funding from the American Heart Association (24SCVNCFRE1301274). Dr Furie reports compensation from Janssen Biotech for consultant services. The other authors report no conflicts.

Publication types

Substances